번호 | 종목명 | 밸류 스코어 |
주가 | 배당금 | 시총 ▼ | PER | PBR | ROE | DY | 52주 가격범위 |
---|---|---|---|---|---|---|---|---|---|---|
1 | 삼성전자 | 79.7 | 55,300 | 1,444 | 3,301,290 | 10.3 | 0.88 | 8.53% | 2.61% |
49,900 88,800 |
2 | 삼성바이오로직스 | 69.4 | 938,000 | 0 | 667,612 | 64.9 | 6.46 | 9.96% | 0.00% |
698,000 1,113,000 |
3 | ○○○ | 75.5 | 218,500 | 11,400 | 457,574 | 3.7 | 0.45 | 12.31% | 5.22% |
179,800 299,500 |
4 | ○○ | 80.4 | 98,100 | 5,600 | 392,261 | 4.1 | 0.75 | 18.47% | 5.71% |
82,200 135,000 |
5 | ○○○○ | 75.3 | 95,600 | 3,060 | 376,213 | 8.5 | 0.66 | 7.73% | 3.20% |
48,900 103,900 |
6 | ○○○○ | 72.2 | 171,400 | 500 | 372,073 | 198.9 | 2.20 | 1.11% | 0.29% |
157,500 241,000 |
7 | ○○○○○ | 71.7 | 193,100 | 1,205 | 310,475 | 20.2 | 1.31 | 6.51% | 0.62% |
151,100 235,500 |
8 | ○○○○ | 77.4 | 55,700 | 2,100 | 280,419 | 6.2 | 0.51 | 8.19% | 3.77% |
36,050 64,600 |
9 | ○○○○○ | 67.7 | 255,000 | 4,500 | 237,137 | 6.8 | 0.55 | 8.21% | 1.76% |
198,000 270,000 |
10 | ○○○○ | 71.4 | 121,800 | 2,550 | 216,541 | 9.6 | 0.60 | 6.22% | 2.09% |
115,400 171,700 |
11 | ○○○○ | 79.6 | 105,200 | 3,700 | 210,400 | 9.2 | 0.53 | 5.78% | 3.52% |
60,000 111,000 |
12 | ○○○○ | 63.5 | 1,008,000 | 15,000 | 208,689 | 33.1 | 2.27 | 6.86% | 1.49% |
435,000 1,543,000 |
13 | ○○○○○○○ | 75.4 | 104,600 | 2,360 | 199,493 | 8.8 | 2.07 | 23.41% | 2.26% |
53,900 107,200 |
14 | ○○○○○ | 53.6 | 259,500 | 1,000 | 178,444 | 10.5 | 0.92 | 8.77% | 0.39% |
235,500 494,500 |
15 | ○○○○ | 75.0 | 374,000 | 16,000 | 177,182 | 9.2 | 1.06 | 11.46% | 4.28% |
231,000 393,500 |
16 | ○○○○○○ | 75.3 | 61,100 | 3,400 | 175,504 | 5.1 | 0.43 | 8.50% | 5.56% |
40,700 69,300 |
17 | ○○○○ | 85.3 | 115,500 | 5,200 | 146,353 | 14.2 | 1.56 | 11.00% | 4.50% |
83,500 124,900 |
18 | ○○○○○○○○ | 70.8 | 367,000 | 1,000 | 132,293 | 29.6 | 10.30 | 34.86% | 0.27% |
78,800 413,500 |
19 | ○○○○○○ | 70.3 | 16,610 | 1,000 | 123,344 | 4.5 | 0.37 | 8.14% | 6.02% |
12,380 17,100 |
20 | ○○○○○ | 77.2 | 56,700 | 3,540 | 121,786 | 10.5 | 1.03 | 9.88% | 6.24% |
48,800 59,000 |
제휴 및 서비스 제공사
「열린보도원칙」 당 매체는 독자와 취재원 등 뉴스이용자의 권리 보장을 위해 반론이나 정정보도, 추후보도를 요청할 수 있는 창구를 열어두고 있음을 알려드립니다.